Deep Track Capital, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001856083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2026 · 63 positions · Total reported value $6.12B · Top-10 concentration 53.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 59.3% · 18 new · 15 cut · 15 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +27.7% · vs SPY +12.9% · Prev Value $6.12B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2026 13F filing, Deep Track Capital, LP disclosed 63 equity positions with a combined reported value of $6.12B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 53.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were XBI ($1.28B), GH ($308.35M), IMVT ($286.33M). By sector, the heaviest allocations are Health Care 69.2%, Other 30.8%. Versus the prior quarter, allocation shifted toward Health Care (+1.8pp) and away from Other (-1.8pp).

Versus the prior quarter, Deep Track Capital, LP opened 18 new positions, trimmed 15 and fully exited 15, a turnover rate of 59.3% of positions. The portfolio's overlap with the prior quarter was 69% of names.

The largest new positions opened in Q1 2026 were ALMS ($149.20M), NUVL ($141.00M), GMAB ($98.28M).

Of the 15 positions fully exited versus the prior quarter, the largest were DVAX ($241.87M), MNMD ($22.45M), XENE ($16.42M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • ALMS ALUMIS INC · $149.20M
  • NUVL NUVALENT INC · $141.00M
  • GMAB GENMAB A/S · $98.28M
  • DFTX DEFINIUM THERAPEUTICS INC · $56.70M
  • CRVS CORVUS PHARMACEUTICALS I · $36.45M
  • ACRS ACLARIS THERAPEUTICS INC · $35.04M
  • MANE VERADERMICS INC · $31.57M
  • SLDB SOLID BIOSCIENCES INC COM NEW · $25.67M

Fully Exited (vs previous quarter)

  • DVAX DYNAVAX TECHNOLOGIES CORP · prev qtr: $241.87M
  • MNMD MIND MEDICINE MINDMED INC · prev qtr: $22.45M
  • XENE XENON PHARMACEUTICALS INC · prev qtr: $16.42M
  • MNPR MONOPAR THERAPEUTICS INC · prev qtr: $6.23M
  • BHVN BIOHAVEN LTD · prev qtr: $5.64M
  • RAPT RAPT THERAPEUTICS INC · prev qtr: $3.74M
  • ANL ADLAI NORTYE GROUP LTD · prev qtr: $49.49K

Insider Transactions (Form 4)

Latest Deep Track Capital, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-06 Conversion Attovia Therapeutics, Inc. 1,957,138 — SEC filing

All insider transactions →

Fund Profile

Deep Track Capital, LP is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 66 US equity positions with a combined value of $6.72B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-120500 (status: Approved), registered 2021-03-12
  • Regulatory AUM (Form ADV): $8.37B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: deeptrackcapital.com

Portfolio Structure

  • 66 positions · $6.72B reported value (Q2 2026)
  • Top 10 holdings = 40.5% of reported value
  • Largest position: GH (GUARDANT HEALTH INC) at 7.6%
  • Average position size: $101.75M

Sector Tilt

  • Health Care 95.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 18 new, 20 added, 15 reduced, 15 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 69.2%
Other 30.8%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 10.00M $1.28B 20.86%
20.86%
Hold
2 3.34M $308.35M 5.04%
5.04%
Add
3 11.53M $286.33M 4.68%
4.68%
Hold
4 3.60M $252.54M 4.12%
4.12%
Add
5 4.30M $249.87M 4.08%
4.08%
Add
6 4.28M $206.29M 3.37%
3.37%
Add
7 1.10M $185.92M 3.04%
3.04%
Reduce
8 4.53M $182.34M 2.98%
2.98%
Reduce
9 19.69M $166.74M 2.72%
2.72%
Add
10 4.11M $165.19M 2.70%
2.70%
Add
11 6.77M $149.20M 2.44%
2.44%
New
12 1.95M $146.43M 2.39%
2.39%
Add
13 1.38M $141.00M 2.30%
2.30%
New
14 3.59M $126.95M 2.07%
2.07%
Add
15 3.16M $125.44M 2.05%
2.05%
Add
16 6.41M $119.46M 1.95%
1.95%
Add
17 3.48M $103.81M 1.70%
1.70%
Reduce
18 2.03M $99.78M 1.63%
1.63%
Reduce
19 6.35M $98.35M 1.61%
1.61%
Reduce
20 3.66M $98.28M 1.60%
1.60%
New
21 1.37M $90.58M 1.48%
1.48%
Reduce
22 1.72M $89.03M 1.45%
1.45%
Add
23 3.35M $82.68M 1.35%
1.35%
Hold
24 2.76M $82.31M 1.34%
1.34%
Reduce
25 4.06M $80.80M 1.32%
1.32%
Add
26 12.16M $67.25M 1.10%
1.10%
Add
27 1.15M $64.96M 1.06%
1.06%
Reduce
28 841.45K $62.49M 1.02%
1.02%
Add
29 1.93M $58.25M 0.95%
0.95%
Reduce
30 2.75M $57.53M 0.94%
0.94%
Add
31 3.00M $56.70M 0.93%
0.93%
New
32 1.07M $56.61M 0.93%
0.93%
Add
33 31.72M $47.26M 0.77%
0.77%
Reduce
34 600.00K $46.14M 0.75%
0.75%
Add
35 6.27M $42.60M 0.70%
0.70%
Add
36 12.00M $42.48M 0.69%
0.69%
Add
37 1.28M $40.73M 0.67%
0.67%
Reduce
38 1.00M $38.49M 0.63%
0.63%
Add
39 2.49M $36.45M 0.59%
0.59%
New
40 2.00M $36.26M 0.59%
0.59%
Reduce
41 1.08M $36.12M 0.59%
0.59%
Add
42 9.35M $35.04M 0.57%
0.57%
New
43 500.00K $31.57M 0.52%
0.52%
New
44 5.74M $30.43M 0.50%
0.50%
Hold
45 4.38M $29.81M 0.49%
0.49%
Hold
46 1.39M $27.27M 0.45%
0.45%
Reduce
47 6.34M $26.18M 0.43%
0.43%
Add
48 3.57M $25.67M 0.42%
0.42%
New
49 1.96M $24.72M 0.40%
0.40%
Hold
50 285.00K $23.99M 0.39%
0.39%
New

FAQ

What did Deep Track Capital, LP buy in 2026-Q1?

In its 2026-Q1 13F filing, Deep Track Capital, LP reported 63 equity positions worth $6.12B in aggregate; its largest disclosed positions were XBI ($1.28B), GH ($308.35M), IMVT ($286.33M).

How large is Deep Track Capital, LP's portfolio?

Deep Track Capital, LP reported $6.12B of long equity holdings across 63 positions as of 2026-Q1. Top-10 holdings account for 53.6% of reported value.

What is Deep Track Capital, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/deep-track-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →